QLGN - Qualigen Therapeutics regains compliance with Nasdaq minimum bid price rule
- Qualigen Therapeutics ( NASDAQ: QLGN ) has received Nasdaq notice, informing the company that it has regained compliance minimum bid price requirement and the matter is now closed.
- The closing bid price of the company’s common stock having been at least $1.00 per share for a minimum of 10 consecutive business days.
- Recently, the company in a bid to regain compliance had announced 1-for-10 reverse stock split .
- Shares are trading down 5.39% premarket.
For further details see:
Qualigen Therapeutics regains compliance with Nasdaq minimum bid price rule